Product Program year 2025 Source: CMS Open Payments

Cytalux

Drug Oncology

NDC 81052-138-10

Open in the dashboard

General payments

$150,939

626 payments

Research payments

$0

0 payments

Through program year 2025, $150,939 in general payments and $0 in research payments were reported against Cytalux (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $97,976 522
2024 General $52,963 104

Breakdown

Who paid General payments · program years 2024–2025
  1. On Target Laboratories, Inc $150,939 626 payments
Top recipients General payments · program year 2025
  1. Nicholas Baker Thoracic Surgery (Cardiothoracic Vascular Surgery) · Pittsburgh, PA $30,281 31% · 23 payments
  2. Matthew Puc Thoracic Surgery (Cardiothoracic Vascular Surgery) · Fountain Hill, PA $9,283 9% · 8 payments
  3. Maheswari Senthil Surgical Oncology · Duarte, CA $8,629 9% · 3 payments
  4. Colleen Gaughan Thoracic Surgery (Cardiothoracic Vascular Surgery) · Celebration, FL $5,335 5% · 4 payments
  5. Robert Wenham Gynecologic Oncology · Tampa, FL $3,795 4% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Thoracic Surgery (Cardiothoracic Vascular Surgery) $71,088 73% · 161 practitioners
  2. Gynecologic Oncology Obstetrics & Gynecology $8,816 9% · 46 practitioners
  3. Surgical Oncology Surgery $8,671 9% · 2 practitioners
  4. Surgery $3,916 4% · 18 practitioners
  5. Physician Assistant $1,163 1% · 30 practitioners

The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $44,158 45% · 27 recipients
  2. Florida $12,899 13% · 35 recipients
  3. California $11,432 12% · 32 recipients
  4. Illinois $7,312 7% · 45 recipients
  5. Connecticut $3,523 4% · 2 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

626 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record